Loading...
Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.
Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...
Na minha lista:
| Udgivet i: | J Clin Pathol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
1982
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7047575/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.35.7.740 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|